Recent Updates
Recently added Catalysts
CLDX Positive Sentiment Score: 70/100

Celldex Therapeutics to Present at Upcoming Investor Conferences

Thursday, September 12, 2024 1 min read
Key Takeaway: Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced its participation in two upcoming investor conferences, namely the 2024 Cantor Global Healthcare Conference on September 17 and TD Cowen's Chronic Urticaria Summit on September 20. Management will engage in fireside chats at these events, with live webcasts planned for public access. This initiative highlights the company's commitment to transparency and active engagement with investors as they develop innovative therapeutics for patients with severe conditions.

Market Sentiment Analysis

POSITIVE FACTORS

  • Management will be visible at two significant investor conferences.
  • Live webcasts ensure widespread access to company updates.
  • The company is focused on transformative therapeutics.

Full Press Release Details

HAMPTON, N.J., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that management will participate in fireside chats at two upcoming conferences:
2024 Cantor Global Healthcare Conference on Tuesday, September 17th at 8:35 a.m. ET
TD Cowen's Chronic Urticaria Summit on Friday, September 20th at 10:00 a.m. ET
Live webcasts of the presentations will be available on the "Events & Presentations” page of the "Investors & Media" section of the Celldex website. Replays will be available for 90 days following the event.
About Celldex Therapeutics, Inc.
Celldex is a clinical stage biotechnology company leading the science at the intersection of mast cell biology and the development of transformative therapeutics for patients. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with severe inflammatory, allergic, autoimmune and other devastating diseases. Visit www.celldex.com.
Senior Vice President, Corporate Affairs & Administration
scavanaugh@celldex.com
ptill@meruadvisors.com

Frequently Asked Questions

When is the 2024 Cantor Global Healthcare Conference?

The conference is on September 17th at 8:35 a.m. ET.

When will the TD Cowen's Chronic Urticaria Summit take place?

The summit is scheduled for September 20th at 10:00 a.m. ET.

How can I watch the Celldex presentations live?

Live webcasts can be accessed on the 'Events & Presentations' page of the Celldex website.

How long will the presentation replays be available?

Replays will be available for 90 days after the event.

What is Celldex Therapeutics focused on?

Celldex specializes in developing therapeutics targeting mast cell biology.

Tags: CLDX Viatris Investor Conferences Healthcare Celldex Therapeutics investor conference biotechnology therapeutics
Last updated: Sep 12, 2024